Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

Peptide Database

265 therapeutic peptides with research summaries, clinical findings, and regulatory status.

Showing 1–14 of 14 in LongevityClear filters
LongevityResearch Phase

Epithalon (Epitalon)

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide produced by the pineal gland. Epithalon activates telomerase, the…

Subcutaneous injection, Intravenous
LongevityResearch Phase

MOTS-c

A mitochondrial-derived peptide encoded by the 12S rRNA gene of mitochondrial DNA. MOTS-c is a 16-amino acid peptide that acts as an exercise mimetic…

Subcutaneous injection
LongevityResearch Phase

Humanin

A 24-amino acid mitochondrial-derived peptide encoded within the 16S rRNA region of mitochondrial DNA. Humanin exerts cytoprotective and…

Subcutaneous injection, Intravenous
LongevityIn Clinical Trials

NAD+ Precursors (NMN)

Nicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular…

Oral, Intravenous, Sublingual
LongevityIn Clinical Trials

SS-31 (Elamipretide)

A mitochondria-targeted tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that selectively concentrates in the inner mitochondrial membrane by binding to…

Subcutaneous injection, Intravenous
LongevityResearch Phase

FOXO4-DRI

A D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells. In senescent cells, FOXO4 sequesters p53 away…

Subcutaneous injection, Intravenous
LongevityFDA Approved

Gonadotropin Releasing Hormone (GnRH) Agonists

Gonadotropin-releasing hormone agonists are synthetic decapeptide analogues of native GnRH that initially stimulate and then suppress gonadotropin…

Subcutaneous injection, Intramuscular injection, Subcutaneous implant, Intranasal
LongevityResearch Phase

Klotho Peptide

Klotho is a transmembrane protein of approximately 1012 amino acids that exists in membrane-bound and secreted forms, with the soluble ectodomain…

Intravenous
LongevityResearch Phase

Sirtuin-Activating Peptides

Sirtuin-activating peptides represent a class of investigational compounds designed to enhance the enzymatic activity of sirtuins, a family of…

Subcutaneous injection
LongevityIn Clinical Trials

Mitochondrial-Targeted Peptides (MTP)

Mitochondrial-targeted peptides are short synthetic sequences, typically 2 to 8 amino acids, designed to localize to mitochondria and protect against…

Subcutaneous injection, Intravenous
LongevityInvestigational

Thymulin (Zn-FTS)

Thymulin is a nonapeptide hormone secreted by thymic epithelial cells that requires zinc for biological activity and is also referred to as facteur…

Subcutaneous injection
LongevityInvestigational

Gerontin (Pineal Gland Extract)

Gerontin refers to peptide fractions derived from pineal gland extracts studied primarily in Russian gerontology research. These preparations are…

Subcutaneous injection
LongevityInvestigational

Vilon (Lys-Glu)

Vilon is a synthetic dipeptide consisting of lysine and glutamic acid (Lys-Glu) developed as part of the Khavinson bioregulator peptide research…

Subcutaneous injection, Oral
LongevityInvestigational

Bioregulator Peptides (Khavinson)

Bioregulator peptides are a class of short synthetic peptides, typically 2 to 4 amino acids in length, developed by Russian researcher Vladimir…

Subcutaneous injection, Oral, Intramuscular injection

All 265 peptides

Complete index, every profile, one click away.

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association reviews licensure but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. HIPAA-compliant infrastructure. The Peptide Association is not a medical practice.